The latest call
FetchingElanco Animal Health Incorporated reported on November 6, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
ELAN · NYSE · Healthcare · Drug Manufacturers Specialty and Generic
$26.79+1.1%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 6, 2026
Company outlook: revenue of $5.2B to $5.2B for Fiscal year 2026 — up 9.6% on a year earlier
Just reported
From Elanco Animal Health Incorporated's results release of November 6, 2026; its quarterly report has since been filed.
Actual
$1.27B
+11% y/y
-7.5% q/q
Guided
—
No guide given
Actual
$0.27
Guided
$0.19
midpoint
EPS, GAAP: $0.04
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $1.3B | $1.1B | +11.26% |
| Profit | $18M | -$34M | +152.94% |
| Profit per share | $0.04 | -$0.07 | +157.14% |
| Free Cash Flow | $156M | $127M | +22.83% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Elanco Animal Health Incorporated reported on November 6, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“Elanco achieved significant adjusted gross margin expansion in the third quarter, up 300 basis points reflecting accelerating price gains to 4% year-over-year and beneficial mix, as well as early progress on our Elanco Ascend productivity initiatives,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
The quote and the company description come from Elanco Animal Health Incorporated’s Item 2.02 8-K filed November 6, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Q4 2026
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.